| 000 | 01738 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514205355.0 | ||
| 264 | 0 | _c20050401 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 024 | 7 |
_a10.1038/sj.leu.2403548 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLevine, R L | |
| 245 | 0 | 0 |
_aKIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32). _h[electronic resource] |
| 260 |
_bLeukemia _cJan 2005 |
||
| 300 |
_a27-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 14 |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 5 |
| 650 | 0 | 4 | _aCloning, Molecular |
| 650 | 0 | 4 | _aDNA Primers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 | _aIn Situ Hybridization, Fluorescence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyeloproliferative Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptor, Platelet-Derived Growth Factor beta _xgenetics |
| 650 | 0 | 4 | _aTranslocation, Genetic |
| 700 | 1 | _aWadleigh, M | |
| 700 | 1 | _aSternberg, D W | |
| 700 | 1 | _aWlodarska, I | |
| 700 | 1 | _aGalinsky, I | |
| 700 | 1 | _aStone, R M | |
| 700 | 1 | _aDeAngelo, D J | |
| 700 | 1 | _aGilliland, D Gary | |
| 700 | 1 | _aCools, J | |
| 773 | 0 |
_tLeukemia _gvol. 19 _gno. 1 _gp. 27-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2403548 _zAvailable from publisher's website |
| 999 |
_c15186542 _d15186542 |
||